Bruce Cree, MD, PhD, MAS, FAAN

Professor of clinical neurology, and George A. Zimmermann Endowed Professor in Multiple Sclerosis, Department of Neurology, University of California San Francisco

Articles

Ublixtumab’s Effect on Measures of MS Disability: Bruce Cree, MD, PhD, MAS, FAAN

April 17, 2022

The clinical research director of the UCSF Multiple Sclerosis Center discussed the recently presented analysis on ublituximab’s effect on disability in relapsing MS and the critical need to focus on improving quality of life. [WATCH TIME: 4 minutes]

New Sponsors, Potential Development in NMOSD: Bruce Cree, MD, PhD, MAS, FAAN

October 24, 2021

Following the approval of 3 treatments for the disease, the clinical research director of the UCSF Multiple Sclerosis Center commented on the implications for the clinical development pipeline. [WATCH TIME: 4 minutes]

Recent Advances and New Therapies for NMOSD: Bruce Cree, MD, PhD, MAS, FAAN

October 11, 2021

The clinical research director of the UCSF Multiple Sclerosis Center provided an overview on the state of care for NMOSD, specifically the development of inebilizumab, satralizumab, and eculizumab. [WATCH TIME: 6 minutes]